Table 1.
Patient characteristics
| Characteristic | Entire Group (n = 30) |
|---|---|
| Age (years) | 57 ± 11 |
| Male gender | 24 (80%) |
| Vital Parameters | |
| Systolic Blood Pressure (mmHg) | 131 ± 24 |
| Diastolic Blood Pressure (mmHg) | 78 ± 17 |
| Height (cm) | 173 ± 12 |
| Weight (kg) | 85 ± 14 |
| CAD Risk Factors | |
| Diabetes mellitus | 10 (33%) |
| Hypertension | 17 (57%) |
| Family History of CAD | 7 (23%) |
| Current Smoker | 13 (43%) |
| Hyperlipidemia | 14 (47%) |
| Medications | |
| Statins | 30 (100%) |
| Beta-blockers | 30 (100%) |
| Aspirin | 30 (100%) |
| Thienopyridine | 30 (100%) |
| ACE-I or ARB | 30 (100%) |
| Peak Troponin | |
| Troponin T, ng/ml (n = 25) | 7.3 ± 4.5 |
| Troponin I, ng/ml (n = 5) | 39.6 ± 18.2 |
| Primary Treatment | |
| PCI | 28 (94%)a |
| Lytics | 1 (3%) |
| None | 1 (3%)b |
| Infarct Related Artery | |
| LAD | 13 (43%) |
| RCA | 12 (40%) |
| LCx | 5 (17%) |
CAD coronary artery disease, ACE-inhibitor angiotensin-converting-enzyme inhibitor, PCI percutaneous coronary intervention, LAD left anterior descending coronary artery, RCA right coronary artery, LCx left circumflex coronary artery
aIn 2 patients PCI was not successful
bPresented later than 24 h